EMBO travel grants and registration fee waivers are allocated on the basis of the quality of the submitted abstract.Īpplicants do not need to apply separately for these but should indicate on the registration form if they wish to be considered.Īdditional travel grants are available for EMBC Associate Member States Chile, India, Singapore and Taiwan. Selection of awardees is handled directly by the organizers. Travel grants and registration fee waivers are available for participants. Travel grants and registration fee waivers Specific time slots will be assigned for each participant to be present in person with his/her poster for direct scientific interaction. The poster size should be 1 m x 1.5 m (length x height) or A0 portrait. All selected participants will give their presentations in the form of posters. Oral presentations and flash talks will be selected from submitted abstracts and a number of slots will be reserved for early career researchers. Participants will be accepted by registration order. The registration fee should be paid no later than September 15th Meals (except dinner of the second night).Organisers are encouraged to implement measures to make the meeting environmentally more sustainable.Ī) Meeting is limited to 200 participants (including invited speakers).ī) Abstract submission and poster presentation are encouragedĬ) Registration will be stopped on 15th September or earlier if all slots are covered.ĭ) Payment is required in order to validate this registration. We envision a truly interdisciplinary meeting with presentations on bacterial defense mechanisms, structural biology, functional genomics and therapeutic applications.ĮMBO Courses and Workshops are selected for their excellent scientific quality and timelines, provision of good networking activities for all participants and speaker gender diversity (at least 40% of speakers must be from the underrepresented gender). This EMBO Workshop aims to connect researchers studying the CRISPR-Cas immune defense system with researchers developing and applying genome editing tools in biomedical research and the clinics. In addition, several clinical trials based on CRISPR-Cas genome editing technologies have started to treat patients suffering from genetic diseases. In recent years this tool has been employed to generate transgenic microorganisms, plants and animals for research and biotechnological applications. More than a decade of research on understanding and characterizing bacterial CRISPR-Cas defense systems led to the development of the powerful CRISPR-Cas genome editing technology.

Download сентябрь 2023 года